DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trileptal (Oxcarbazepine) - Published Studies

 
 



Trileptal Related Published Studies

Well-designed clinical trials related to Trileptal (Oxcarbazepine)

Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine. [2011.06]

Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers. [2010.08]

[Efficacy and safety of the monotherapy with trileptal (oxcarbazepine) in children and adolescents.] [2010]

Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study. [2009.04]

Effect of Oxcarbazepine in the Treatment of Agitation and Aggression in Severe Dementia. [2009.02.02]

Bipolar I and II disorder residual symptoms: Oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. [2009.02.01]

Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. [2009]

Bioequivalence of oxcarbazepine oral suspension vs. film-coated tablet in healthy Chinese male subjects. [2008.10]

A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. [2008.06]

A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. [2008.03.17]

Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study. [2008.02.12]

Parent drug and/or metabolite? Which of them is most appropriate to establish bioequivalence of two oral oxcarbazepine formulations in healthy volunteers? [2007.07]

Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study. [2007.07]

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. [2007.03.24]

Diagnostics for confounding in PK/PD models for oxcarbazepine. [2007.01.30]

Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy. [2006.12.26]

A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder. [2006.08.30]

Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. [2006.08.22]

A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. [2006.07]

Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. [2006.06]

Oxcarbazepine versus phenytoin monotherapy for epilepsy. [2006.04.19]

Diagnostics for confounding in PK/PD models for oxcarbazepine. [2006.04.13]

A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients. [2006.04]

Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial. [2005.12]

Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine. [2005.12]

Oxcarbazepine as add-on therapy in Thai epileptic patients with refractory partial seizures. [2005.11]

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. [2005.10]

Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. [2004.12]

Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy. [2004.11]

Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. [2004.11]

Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. [2004.06]

Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy. [2004.05]

Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy. [2003.09]

Pharmacokinetic drug interactions in children taking oxcarbazepine. [2003.08]

Assessment of the bioequivalence of two oxcarbazepine oral suspensions versus a film-coated tablet in healthy subjects. [2003.07]

Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. [2003.04]

Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects. [2002.11]

Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. [2001.09.11]

Oxcarbazepine, an antiepileptic agent. [2001.05]

Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. [2000.12]

Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. [2000.06.27]

Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. [2000.06.27]

Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women. [1999.06]

Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. [1999.03.10]

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. [1997.06]

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. [1997.06]

A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. [1997.03]

Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine. [1995.10]

The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers. [1994.08]

Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy. [1994.08]

A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. [1994.01]

The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid. [1993.10]

Absence of interaction between oxcarbazepine and erythromycin. [1992.08]

Effects of oxcarbazepine and carbamazepine on the central nervous system: computerised analysis of saccadic and smooth-pursuit eye movements. [1992.06]

Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. [1992.05]

Oxcarbazepine does not interact with cimetidine in healthy volunteers. [1992.04]

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. [1989.01]

Oxcarbazepine (GP 47.680): a possible alternative to carbamazepine? [1987.11]

Well-designed clinical trials possibly related to Trileptal (Oxcarbazepine)

Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. [2012]

Interventions for preventing neuropathy caused by cisplatin and related compounds. [2011.02.16]

Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial. [2008.02]

Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations? [2008.02]

Management of neuropathic pain. [2007.08]

Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. [2007.07]

How reliable is early treatment response in predicting long-term seizure outcome? [2007.06]

Seizure-Free Outcome in Randomized Add-on Trials of the New Antiepileptic Drugs. [2007.05.23]

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. [2006.07]

[Use of antiepileptic drugs in bipolar disorder] [2006.01]

Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans. [2004.08]

Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans. [2003]

Other research related to Trileptal (Oxcarbazepine)

Impact of oxcarbazepine sulfate metabolite on incurred sample reanalysis and quantification of oxcarbazepine. [2011.05]

Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice. [2011.04]

Effects of chronic treatment with valproate and oxcarbazepine on testicular development in rats. [2011.04]

Seizure after intrathecal baclofen bolus in a multiple sclerosis patient treated with oxcarbazepine. [2011.04]

Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population. [2011.03]

Pharmacological interaction between oxcarbazepine and two COX inhibitors in a rat model of inflammatory hyperalgesia. [2011.01]

Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine. [2011]

Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy. [2010.12]

[Multicenter observational study of the effect of oxcarbazepine on the general well-being of adults with partial epilepsy]. [2010.11.30]

Phenytoin toxicity secondary to an oxcarbazepine-phenytoin 2C19 interaction. [2010.11]

Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy. [2010.11]

Additive interactions of pregabalin with lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis for non-parallel dose-response relationship curves. [2010.10]

Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy. [2010.09.15]

Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy. [2010.07]

Effects of oxcarbazepine and carbamazepine on driving ability: a double-blind, randomized crossover trial with healthy volunteers. [2010.05]

Safety profile of oxcarbazepine: results from a prescription-event monitoring study. [2010.05]

Interactions of 1-methyl-1,2,3,4-tetrahydroisoquinoline with lamotrigine, oxcarbazepine, pregabalin, and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis. [2010.05]

Caffeine reverses antinociception by oxcarbazepine by inhibition of adenosine A1 receptors: insights using knockout mice. [2010.04.12]

The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome. [2010.04]

Oxcarbazepine for the treatment of trichotillomania. [2010.03]

[Therapeutic drug monitoring of oxcarbazepine] [2010.01]

Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine. [2010]

Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers. [2010]

Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures. [2009.10.07]

Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal--a RCT. [2009.09]

The effect of oxcarbazepine on bone metabolism. [2009.09]

Effect of oxcarbazepine on sleep architecture. [2009.07]

The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine. [2009.05.06]

Oxcarbazepine treatment of restless legs syndrome: three case reports. [2009.05]

[Primary erythermalgia: efficacy of oxcarbazepine] [2009.04]

Oxcarbazepine use in paroxysmal kinesigenic dyskinesia: report on four patients. [2009.04]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014